KR100512820B1 - Compositions and Methods for the Treatment of Tumor - Google Patents

Compositions and Methods for the Treatment of Tumor

Info

Publication number
KR100512820B1
KR100512820B1 KR10-2004-7011453A KR20047011453A KR100512820B1 KR 100512820 B1 KR100512820 B1 KR 100512820B1 KR 20047011453 A KR20047011453 A KR 20047011453A KR 100512820 B1 KR100512820 B1 KR 100512820B1
Authority
KR
South Korea
Prior art keywords
tumor
compositions
treatment
methods
Prior art date
Application number
KR10-2004-7011453A
Other languages
Korean (ko)
Other versions
KR20040073587A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/003565 external-priority patent/WO2001053486A1/en
Publication of KR20040073587A publication Critical patent/KR20040073587A/en
Application granted granted Critical
Publication of KR100512820B1 publication Critical patent/KR100512820B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR10-2004-7011453A 1999-05-11 2000-02-11 Compositions and Methods for the Treatment of Tumor KR100512820B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13345999P 1999-05-11 1999-05-11
US60/133,459 1999-05-11
PCT/US2000/003565 WO2001053486A1 (en) 1999-03-08 2000-02-11 Compositions and methods for the treatment of tumor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR10-2001-7011391A Division KR100512819B1 (en) 1999-03-08 2000-02-11 Compositions and Methods for the Treatment of Tumor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7019194A Division KR20050004241A (en) 1999-05-11 2000-02-11 Compositions and Methods for the Treatment of Tumor

Publications (2)

Publication Number Publication Date
KR20040073587A KR20040073587A (en) 2004-08-19
KR100512820B1 true KR100512820B1 (en) 2005-09-07

Family

ID=33538658

Family Applications (2)

Application Number Title Priority Date Filing Date
KR10-2004-7011453A KR100512820B1 (en) 1999-05-11 2000-02-11 Compositions and Methods for the Treatment of Tumor
KR10-2004-7019194A KR20050004241A (en) 1999-05-11 2000-02-11 Compositions and Methods for the Treatment of Tumor

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR10-2004-7019194A KR20050004241A (en) 1999-05-11 2000-02-11 Compositions and Methods for the Treatment of Tumor

Country Status (2)

Country Link
KR (2) KR100512820B1 (en)
NZ (1) NZ523209A (en)

Also Published As

Publication number Publication date
KR20050004241A (en) 2005-01-12
NZ523209A (en) 2004-12-24
KR20040073587A (en) 2004-08-19

Similar Documents

Publication Publication Date Title
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU2003200731A1 (en) Compositions and methods for the treatment of tumor
AU2003200740A1 (en) Compositions and methods for the treatment of tumor
AU2495200A (en) Compositions and methods for the treatment of tumor
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2212299A (en) Compositions and methods for the treatment of tumor
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
MXPA02004770A (en) Therapeutic compositions and methods of use thereof.
HUP0201436A2 (en) Methods and compositions for treating solid tumors
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
HUP0104688A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
ZA200301204B (en) Compositions and methods for the diagnosis and treatment of tumor
PL352931A1 (en) Compositions and uses of et743 for treating cancer
IL148579A0 (en) Oncolytic combinations for the treatment of cancer
AU8678501A (en) Compositions and methods for the diagnosis and treatment of tumor
IL158206A0 (en) Compositions and methods for the prevention and treatment of human prostate cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
IL143212A0 (en) Compositions and methods for the treatment of tumor
PL368035A1 (en) Compositions and methods for the treatment of cancer
PL350863A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
IL147410A0 (en) L-acetylcarnitine and l-propionylcarnitine containing composition for the prevention and treatment of kidney dysfunctions and diseases
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
IL149281A0 (en) Treatment of cancer
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
A107 Divisional application of patent
AMND Amendment
E601 Decision to refuse application
AMND Amendment
J201 Request for trial against refusal decision
E902 Notification of reason for refusal
B701 Decision to grant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100825

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee